start portlet menu bar end portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Inicio Conocimiento Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

European Sea Bass (Dicentrarchus labrax) is a marine fish species with a high commercial value, especially in the Mediterranean countries and Europe. Vibriosis caused by Listonella (Vibrio) anguillarum is a common disease in Sea Bass that has led to significant economic losses to date. Therefore, development and use of preventive strategies can evade these associated mortalities [1].

Descarga este artículo

4,75 MB

Sobre este artículo

Autores

Ruiz, M. C.; Robles, R.; Callol, C.; Colomer, S.; Vendrell, D.; Perelló, M. Bermúdez, L.

Resumen

Clear differences in the mortality rates between vaccinated and control groups were observed. The mortality rates reported in vaccinated groups ranged between 21.67 and 22.22 % whereas the mortality rates in control groups were of 60-97.78 %. Deaths were observed between 24 and 72 hours after challenge.

Servicios relacionados

HIPRA Diagnos

Productos relacionados

ICTHIOVAC® VR

Publicaciones relacionadas

Guía para la toma de muestras bacteriológicas en peces Safety and efficacy of an inactivated vaccine against Lactococcus garvieae in rainbow trout (Oncorhynchus mykiss) Lactococcus garvieae in fish: A review

Compartir en

start portlet menu bar

Efficacy of ICTHIOVAC® VR against Listonella anguillarum serovar O2α in European sea bass fry and juveniles

Display portlet menu
end portlet menu bar

Ver también

Publicaciones

Guía para la toma de muestras bacteriológicas en peces

29-04-2019
Fichas de enfermedades

Lactococcosis in trout

12-01-2017
Noticia

Presentamos una nueva solución para lubina frente al VNN

03-06-2019